May 29, 2019 -
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares have been under pressure since mid-May, when it was accused along with other generic companies for inflati
May 29, 2019 - An honest appraisal of the situation facing Teva.A discussion of Teva's lawsuits.An estimation of Teva's normalized FCF.Why Teva today is dramatically undervalued.
May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
May 29, 2019 - Companies in the news are:
UBER, TEVA, AMD and ASGN
May 28, 2019 - Tough industry conditions took their toll on some stocks.
May 28, 2019 - A larger-than-expected legal settlement might be a harbinger of things to come.
May 28, 2019 - Teva Pharmaceutical Industries (TEVA -12.9%) commences the U.S. commercial launch of its generic version of Gilead Sciences' (GILD -3.2%) angina med Ranexa (ranolazine) Extended-Release Tablets, 500 m
May 28, 2019 - Oklahoma state prosecutors blasted J&J in the first day of a landmark opioid trial Tuesday, saying it ran a "deceitful, multibillion-dollar brainwashing campaign" that led to more than 46,000 deaths in the state over a decade.
May 28, 2019 - Gainers: Soliton (NASDAQ:SOLY) +80%. Biocept (NASDAQ:BIOC) +25%. Armata Pharmaceuticals (NYSEMKT:ARMP) +16%. OncoSec Medical (NASDAQ:ONCS) +15%. MYnd Analytics (NASDAQ:MYND) +10%.Losers: Kezar Life Sc
May 28, 2019 - Without admitting any wrongdoing, Teva Pharmaceutical Industries (NYSE:TEVA) has agreed to settle claims by the U.S. state of Oklahoma over its role in the opioid crisis there via a one-time payment o